Key result
Review assesses myocarditis and cardiac sequelae risk in mild or asymptomatic COVID-19.
Why the study?
There is concern about the risk of myocarditis and cardiac sequelae in patients with mild or asymptomatic COVID-19, including those previously healthy, which is not well characterized.
This review aims to compile evidence regarding the risk of myocarditis and other cardiac sequelae in patients who experience mild or asymptomatic COVID-19.
Answers are grounded in this paper and cite their sources.
May guide monitoring for cardiac issues after mild COVID-19; leaves open precise incidence and screening needs.
The coronavirus disease 2019 (COVID-19) pandemic has taken a massive toll on healthcare systems internationally. Severe illness has been seen in a range of patient populations, but those living with cardiovascular disease have suffered to a greater extent, likely because of their comorbidities. In patients with diabetes, hypertension, heart failure, and other chronic illnesses, COVID-19 has manifested severe illnesses such as coagulopathies, myocarditis, and arrhythmias, complicating the disease course for those already suffering from underlying illness. There have been numerous studies done exploring the cardiovascular complications of COVID-19. Some of the more concerning findings have revealed a correlation between severe illness and the increasing likelihood for developing cardiovascular manifestations. However, what is more concerning were the studies revealing the presence of myocarditis and other cardiac sequelae in previously healthy patients with mild or asymptomatic COVID-19. The goal of this article is to review the literature to compile information available about whether there is a significant risk of myocarditis in those patients who do not develop severe initial COVID-19 disease.
No takes yet. Share an insight, caveat, or question.
Bailey et al. (2022) conducted a review in COVID-19 and Myocarditis. Mild or asymptomatic COVID-19 was evaluated on Risk of myocarditis. This review explores the literature to assess the risk of myocarditis and other cardiac sequelae in previously healthy patients with mild or asymptomatic COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: